K.J. Harrison & Partners’s Gilead Sciences GILD Stock Holding History

K.J. Harrison & Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,678	Closed	-$408K	–	219
2025 Q2	$408K	Buy	3,678 +8	+0.2%	+$851	0.07%	161
2025 Q1	$411K	Hold	3,670	–	–	0.08%	147
2024 Q4	$337K	Sell	3,670 -30	-0.8%	-$2.7K	0.05%	166
2024 Q3	$319K	Hold	3,700	–	–	0.05%	190
2024 Q2	$254K	Sell	3,700 -3,015	-45%	-$201K	0.04%	183
2024 Q1	$492K	Sell	6,715 -950	-12%	-$73.1K	0.08%	165
2023 Q4	$621K	Buy	+7,665	New	+$596K	0.11%	144
2023 Q3	–	Sell	-12,205	Closed	-$937K	–	149
2023 Q2	$937K	Buy	12,205 +9,000	+281%	+$718K	0.17%	130
2023 Q1	$266K	Buy	+3,205	New	+$265K	0.05%	184

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

K.J. Harrison & Partners's GILD Position: Q3 2025 in Review

K.J. Harrison & Partners sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,678 shares — an estimated $408K sold.

K.J. Harrison & Partners first reported a position in GILD in Q1 2023 and held it in 9 quarters. The position peaked at $937K in Q2 2023. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

K.J. Harrison & Partners reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
K.J. Harrison & Partners sold 3,678 Gilead Sciences shares in Q3 2025, an estimated $408K.
K.J. Harrison & Partners first reported a position in Gilead Sciences in Q1 2023 and held it in 9 quarters.
K.J. Harrison & Partners's Gilead Sciences position peaked at $937K in Q2 2023.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on K.J. Harrison & Partners's 13F filing for Q3 2025, filed 12 Nov 2025.